China Health EBITDA
What is the EBITDA of China Health?
The EBITDA of China Health Group Inc. is ¥33.415M
What is the definition of EBITDA?
EBITDA is a company’s earnings before interest, taxes, depreciation, and amortization and is an accounting measure calculated using a company’s net earnings, before interest expenses, taxes, depreciation and amortization are subtracted, as a proxy for a company’s current operating profitability.
ttm (trailing twelve months)
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA of companies in the Health Care sector on HKSE compared to China Health
What does China Health do?
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
Companies with ebitda similar to China Health
- Select Harvests has EBITDA of AUD$33.210M
- The Tra.Desk A Dl ,000001 has EBITDA of $33.264M
- Gascogne SA has EBITDA of €33.269M
- Brooks MacDonald Plc has EBITDA of £33.312M
- LHN has EBITDA of SGD$33.325M
- CTI Logistics has EBITDA of AUD$33.366M
- China Health has EBITDA of ¥33.415M
- Ortel Communications has EBITDA of ₨33.460M
- Prajay Engineers Syndicate has EBITDA of ₨33.507M
- Monash IVF has EBITDA of AUD$33.513M
- Madhav Marbles and Granites has EBITDA of ₨33.514M
- Revolve Inc has EBITDA of $33.546M
- Prairie Provident Resources has EBITDA of CAD$33.675M